Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BriaCell Therapeutics Corp (TSE:BCT)
TSX:BCT
RESEARCH TOOLSreports
BriaCell Therapeutics (BCT) Ownership - Who Owns BriaCell Therapeutics?
26 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 28, 2024 | Marc Lustig Non Executive,director, >10% Owner | Bought | $2004516 |
| May 20, 2024 | Marc Lustig Non Executive,director, >10% Owner | Bought | $2000001 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,381,287 | Insider | 73.18% | 18,332,363 | |
| 6,761,500 | Insider | 36.98% | 9,263,255 | |
| 6,344,715 | Insider | 34.70% | 8,692,260 | |
| 3,855,000 | Insider | 21.08% | 5,281,350 | |
| 2,857,142 | Insider | 15.63% | 3,914,285 | |
| 2,542,935 | Insider | 13.91% | 3,483,821 | |
| 2,007,839 | Insider | 10.98% | 2,750,739 | |
| 495,225 | Insider | 2.71% | 678,458 | |
| 266,167 | Institution | 1.46% | 267,232 | |
| 218,500 | Insider | 1.19% | 299,345 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 266,167 | Institution | 1.46% | 267,232 | |
| 7,229 | Institution | 0.04% | 7,258 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns BriaCell Therapeutics Corp (TSE:BCT)?
Currently, no data Available
What percentage of BriaCell Therapeutics Corp (TSE:BCT) stock is held by institutional investors?
Currently, no data Available
What percentage of BriaCell Therapeutics Corp (TSE:BCT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of BriaCell Therapeutics Corp (TSE:BCT)?
Charles Louis Wiseman owns the most shares of BriaCell Therapeutics Corp (TSE:BCT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.